What Is The Comparative Market Size Outlook For The Hematology Analyzers and Reagents Market Over The 2026–2030Timeframe?
The hematology analyzers and reagents market size has grown marginally in recent years. It will grow from $5.25 billion in 2025 to $5.26 billion in 2026 at a compound annual growth rate (CAGR) of 0.2%. The growth in the historic period can be attributed to increasing prevalence of anemia and blood-related disorders, growing hospital and diagnostic laboratory infrastructure, reliance on manual and semi-automated analyzers, rising demand for complete blood count testing, expansion of clinical diagnostic services.
The hematology analyzers and reagents market size is expected to see strong growth in the next few years. It will grow to $7.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to integration of AI-based cell analysis, rising adoption of fully automated hematology systems, growing focus on precision medicine and personalized diagnostics, expansion of diagnostic centers in emerging markets, increasing demand for advanced reagents and consumables. Major trends in the forecast period include rising adoption of automated and high-throughput hematology analyzers, growing demand for accurate and early diagnosis of blood disorders, increasing use of point-of-care hematology testing, expansion of reagent rental and consumable-based business models, enhanced focus on standardization and quality control in hematology testing.
Claim Your Free Report Sample Today:
Which Strategic Drivers Are Powering The Rise Of The Hematology Analyzers and Reagents Market?
The rise in the prevalence of blood disorders is expected to drive the growth of the hematology analyzers and reagents market going forward. A blood disorder is a medical condition that affects the normal functioning of blood components, such as red blood cells, white blood cells, or platelets. Hematology analyzers and reagents are crucial tools for diagnosing and monitoring blood disorders, including cancer, by analyzing blood cell counts and morphology. For instance, in July 2024, according to Cancer Research UK, a UK-based charity, the average number of new Hodgkin lymphoma cases per year in the UK is expected to increase from approximately 2,400 cases in 2023-2025 to around 2,900 cases in 2038-2040. As a result, the rise in the prevalence of blood disorders is propelling the hematology analyzers and reagents market forward.
How Do The Key Segment Classifications Define The Strategic Structure Of The Hematology Analyzers and Reagents Market?
The hematology analyzers and reagents market covered in this report is segmented –
1) By Product: Hematology Analyzers, Hemostasis Analyzers, Plasma Protein Analyzers, Hemoglobin Analyzers, Erythrocyte Sedimentation Rate Analyzer, Coagulation Analyzer
2) By Applications: Anemias, Blood Cancers, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, Other Applications
3) By End User: Specialized Research Institutes, Hospitals, Specialized Diagnostic Centers, Other End Users
Subsegments:
1) By Hematology Analyzers: Automated Hematology Analyzers, Semi-Automated Hematology Analyzers
2) By Hemostasis Analyzers: Platelet Function Analyzers, Coagulation Testing Analyzers
3) By Plasma Protein Analyzers: Electrophoresis Analyzers, Immunofixation Analyzers
4) By Hemoglobin Analyzers: Point-Of-Care Hemoglobin Analyzers, Laboratory Hemoglobin Analyzers
5) By Erythrocyte Sedimentation Rate Analyzer: Manual ESR Analyzers, Automated ESR Analyzers
6) By Coagulation Analyzer: Clotting Time Analyzers, Thromboelastography (TEG) Analyzers
Which Rising Trends Are Anticipated To Influence The Future Trajectory Of The Hematology Analyzers and Reagents Market?
Major companies operating in the hematology analyzers and reagents market are focusing on developing innovative solutions, such as automated hematology platform, to enhance diagnostic accuracy, streamline laboratory workflows, and provide more comprehensive patient data. An automated hematology platform (often called a hematology analyzer) is a sophisticated, computer-driven medical laboratory instrument designed to perform a complete blood count (CBC) and other related tests on a blood sample rapidly, accurately, and with minimal human intervention. For instance, in January 2024, HORIBA Medical, a France-based in vitro diagnostics company, launched the Yumizen Helo, a next-generation, fully automated and modular hematology solution. This system integrates a high-throughput analyzer with a digital cell morphology module and an automated reticulocyte module into a single, compact unit. Its key feature is walkaway automation, which uses an intelligent robotic arm to automatically sort and prepare blood smears, significantly reducing manual steps and operator intervention compared to traditional benchtop analyzers that require separate, manual processes for slide preparation and review. This innovation is designed to boost productivity in clinical laboratories by consolidating multiple hematology tasks into one continuous, automated workflow.
Which Major Industry Players Are Recognized As Strong Influencers In The Hematology Analyzers and Reagents Market?
Major companies operating in the hematology analyzers and reagents market are Abbott Laboratories, Bio-Rad Laboratories, Horiba Ltd., Siemens AG, Sysmex Corporation, BioSystems Diagnostics Pvt. Ltd, Boule Diagnostics, Danaher Corporation, Diatron MI PLC, Drew Scientific, EKF Diagnostics, Mindray, Nihon Kohden, Ortho Clinical Diagnostics, Roche, Beckman Coulter, Bayer AG, Heska, Drucker, Instrumentation Laboratory, Abaxis Inc., Accriva Diagnostics, ACON, Diamond Diagnostics, ERBA Diagnostics, Hycel, Maccura Biotechnology Co. Ltd., Genrui Biotech Inc., A&T Corporation, Beijing Succeeder Technology Inc., Diagnostica Stago SAS
Get Your In-Depth Hematology Analyzers and Reagents Market Report Now:
Which Region Currently Accounts For The Largest Share Of The Hematology Analyzers and Reagents Market?
North America was the largest region in the hematology analyzers and reagents market in 2025. Western Europe was the second-largest region in the hematology analyzers and reagents market report. The regions covered in the hematology analyzers and reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment